These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18040753)

  • 1. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease.
    Sabino A; Fernandes AP; Lima LM; Ribeiro DD; Sousa MO; de Castro Santos ME; Mota AP; Dusse LM; das Graças Carvalho M
    J Thromb Thrombolysis; 2009 Jan; 27(1):82-7. PubMed ID: 18040753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.
    Pezzini A; Del Zotto E; Archetti S; Negrini R; Bani P; Albertini A; Grassi M; Assanelli D; Gasparotti R; Vignolo LA; Magoni M; Padovani A
    Stroke; 2002 Mar; 33(3):664-9. PubMed ID: 11872884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.
    Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease.
    Rassoul F; Richter V; Janke C; Purschwitz K; Klötzer B; Geisel J; Herrmann W
    Angiology; 2000 Mar; 51(3):189-96. PubMed ID: 10744006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India.
    Kumar M; Goudihalli S; Mukherjee K; Dhandapani S; Sandhir R
    Metab Brain Dis; 2018 Oct; 33(5):1617-1624. PubMed ID: 29926428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
    Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):869-73. PubMed ID: 26083986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia.
    Shmeleva VM; Kapustin SI; Papayan LP; Sobczyńska-Malefora A; Harrington DJ; Savidge GF
    Thromb Res; 2003; 111(6):351-6. PubMed ID: 14698652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Hanson NQ; Aras O; Yang F; Tsai MY
    Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients.
    Mejia Mohamed EH; Tan KS; Ali JM; Mohamed Z
    Ann Acad Med Singap; 2011 Apr; 40(4):186-91. PubMed ID: 21678004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
    Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
    Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine, MTHFR C677 T, vitamin B12, and folate levels in Thai children with ischemic stroke: a case-control study.
    Sirachainan N; Tapanapruksakul P; Visudtibhan A; Chuansumrit A; Cheeramakara C; Atamasirikul K; Chotsuppakarn S; Areekul S
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):803-8. PubMed ID: 17164649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An MTHFR variant, plasma homocysteine levels and late-onset coronary artery disease in subjects from southern Iran.
    Saffari B; Senemar S; Karimi M; Bahari M; Jooyan N; Yavarian M
    Pak J Biol Sci; 2013 Aug; 16(16):788-95. PubMed ID: 24498831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.
    Nakai K; Itoh C; Nakai K; Habano W; Gurwitz D
    Am J Cardiovasc Drugs; 2001; 1(5):353-61. PubMed ID: 14728017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and methylenetetrahydrofolate reductase in subjects undergoing coronary angiography.
    Lima LM; Carvalho Md; Fernandes AP; Sabino Ade P; Loures-Vale AA; da Fonseca Neto CP; Garcia JC; Saad JA; Sousa MO
    Arq Bras Cardiol; 2007 Feb; 88(2):167-72. PubMed ID: 17384833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.